Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Acute COVID-19, Inflammation, and Depression

NCT05346120 is registered in ClinicalTrials.gov with Sean Savitz as lead sponsor.

NCT NCT05346120
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05346120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Acute COVID-19, Inflammation, and Depression
Lead sponsor
Sean Savitz
Phase
Phase 2
Overall status
Withdrawn
Start date
May 25, 2022
Completion date
May 1, 2024
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

post covid -19 depression